Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina
Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic.
Drugs
Health
Pharma
Drugs
Health
Pharma
WHO issues medical alert on falsified weight-loss, diabetic drugs
The World Health Organization has issued a medical product alert on falsified semaglutides, an active ingredient in Ozempic, a diabetic drug made by.
Drugs
Health
Pharma
Roche to pay $42 million to Ascidian to make RNA exon editing drugs
Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.
Drugs
Medical
Pharma
Israel’s Teva Pharmaceuticals sue Corcept, Optime over drug monoploy
Israel’s Teva Pharmaceuticals has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to.
Drugs
Health
Pharma
Genetic factors may help predict loss of X chromosome in older women
Researchers co-led by the US-based National Cancer Institute have found genetic variants in women that may play a role in promoting abnormal blood.
Drugs
Health
Pharma
FDA approves AstraZeneca’s type-2 diabetes drug in US market
AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according.
Drugs
Health
Pharma
FDA gives approval for Ispen, Genfit’s drug to treat chronic liver disease
The US drug regulator has granted accelerated approval for a drug to treat chronic inflammatory liver disease to Genfit, headquartered in Nord, France,.
Drugs
Health
Pharma
FDA advisers reject psychedelic party drug MDMA to treat PSTD in adults
The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to.
Drugs
Health
Pharma
AstraZeneca, Daiichi’s breast cancer drug trials show rise in survival
HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials.
Drugs
Health
Pharma
US reports a third human case of highly pathogenic avian influenza
A dairy farm worker in Michigan, US, has been infected with highly pathogenic avian influenza from sick cows —the third such case in America.